Pharmacy benefits manager (PMB) executives are testifying before Congress about the price of prescription drugs and how they can be lowered. Some of the questions being asked are in regards to pricing, rebates, and the role of the middle man between pharmacies and drug makers.

Yahoo Finance Reporter Anjalee Khemlani joins Catalysts to break down the testimonies before Congress from PMB executives and what it means for their operations moving forward.

For more expert insight and the latest market action, click here to watch this full episode of Catalysts.

This post was written by Nicholas Jacobino